Vivacelle Bio

Developer of nano-micelles technology-based colloids for restoring blood pressure

placeChicago, Illinois, United States calendar_todayFounded 2011 groups4 employees language vivacellebio.com

Registered entities

Social engagement

Social engagement: 549 social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Other / undisclosed267%

Recent activity

4 Sep 2025
Event
Vivacelle Bio conversation on novel therapy for treating hypovolemia due to septic shock
Coming soon